Literature DB >> 30305464

Postprandial Hyperlipemia is an Indication for Additional Risk in Sitosterolemia.

Misa Ito1,2, Katsunori Ikewaki1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30305464      PMCID: PMC6249361          DOI: 10.5551/jat.ED104

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN: 1340-3478            Impact factor:   4.928


× No keyword cloud information.
  8 in total

Review 1.  Postprandial lipoprotein metabolism in familial hypercholesterolemia: thinking outside the box.

Authors:  Dick C Chan; Gerald F Watts
Journal:  Metabolism       Date:  2011-09-25       Impact factor: 8.694

2.  Serum triglycerides and risk of coronary heart disease among Japanese men and women.

Authors:  H Iso; Y Naito; S Sato; A Kitamura; T Okamura; T Sankai; T Shimamoto; M Iida; Y Komachi
Journal:  Am J Epidemiol       Date:  2001-03-01       Impact factor: 4.897

3.  Atherogenesis: a postprandial phenomenon.

Authors:  D B Zilversmit
Journal:  Circulation       Date:  1979-09       Impact factor: 29.690

Review 4.  Postprandial lipaemia and vascular disease.

Authors:  Genovefa Kolovou; Teik Chye Ooi
Journal:  Curr Opin Cardiol       Date:  2013-07       Impact factor: 2.161

Review 5.  Sitosterolemia.

Authors:  G Salen; S Shefer; L Nguyen; G C Ness; G S Tint; V Shore
Journal:  J Lipid Res       Date:  1992-07       Impact factor: 5.922

Review 6.  Sitosterolemia: diagnosis, investigation, and management.

Authors:  Joan Carles Escolà-Gil; Helena Quesada; Josep Julve; Jesús M Martín-Campos; Lídia Cedó; Francisco Blanco-Vaca
Journal:  Curr Atheroscler Rep       Date:  2014-07       Impact factor: 5.113

7.  Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women.

Authors:  Børge G Nordestgaard; Marianne Benn; Peter Schnohr; Anne Tybjaerg-Hansen
Journal:  JAMA       Date:  2007-07-18       Impact factor: 56.272

8.  Post-prandial Remnant Lipoprotein Metabolism in Sitosterolemia.

Authors:  Hayato Tada; Akihiro Nomura; Atsushi Nohara; Akihiro Inazu; Hiroshi Mabuchi; Masakazu Yamagishi; Masa-Aki Kawashiri
Journal:  J Atheroscler Thromb       Date:  2018-07-12       Impact factor: 4.928

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.